GAD2 and Autoimmunity: Antibodies targeting neuronal surface antigens, such as the glycine receptor, are considered pathogenic [49], but whether GAD65 antibodies are pathogenic or rather a marker of T cell-mediated autoimmunity is an ongoing debate.